L. Hammarstrçm, O. Johansson et al.
4-Hydroxymethyl-2,6-di(quinolin-8-yl)pyridine (15): Degassed H2O
(2 mL) and MeCN (2 mL) were added to a mixture of 14 (0.75 g,
4.2 mmol), 8-quinolinylboronic acid (1.6 g, 9.3 mmol), K2CO3 (1.7 g,
(ESI): m/z: calcd for C39H35N7O3Ru2+ ([M2+]): 375.6; found: 375.4; r.t.:
4.02 min.
[Ru(12)ACTHNUGTRENN(UG MeCN)3]ACHTUNGTREN(NUGN PF6)2 (19): Compound 19 was synthesized by the
12.6 mmol), SPhos (0.086 g, 0.21 mmol) and [PdACTHNURGTNEUNG(dba)2] (0.12 g,
method used for 18 from RuCl3·xH2O (45.6 mg, 0.174 mmol) and 12
(100 mg, 0.174 mmol) to give 19 as a yellow solid (111 mg, 0.102 mmol,
66% yield). 1H NMR (CD3CN): d=9.14 (dd, J=1.4, 5.1 Hz, 2H), 8.62
(dd, J=1.4, 8.3 Hz, 2H), 8.55 (dd, J=1.2, 7.5 Hz, 2H), 8.26 (dd, J=1.1,
8.2 Hz, 2H), 7.87 (m, 4H), 7.70 (dd, J=5.2, 8.3 Hz, 2H), 7.37 (m, 1H),
6.96 (m, 3H), 3.79 (s, 3H), 3.75 (s, 3H), 2.21 (s, 9H), 1.99 ppm (s, 6H);
13C NMR (CD3CN): d=159.6, 158.2, 154.8, 152.7, 151.7, 147.2, 139.9,
139.6, 137.1, 136.1, 135.2, 135.0, 132.8, 131.6, 129.8, 129.7, 129.6, 129.0,
127.3, 123.1, 117.3, 114.2, 113.8, 56.7, 56.3, 21.0, 4.4, 3.8 ppm; LC–MS
(ESI): m/z: calcd for C45H40N6O2Ru2+ ([M2+]): 399.1; found: 398.6; r.t.:
4.57 min.
0.21 mmol). The suspension was then stirred and degassed a further
5 min before being heated to 1308C for 1 h by microwave heating. The
solution was diluted with CH2Cl2, washed with H2O, dried with Na2SO4
and concentrated in vacuo. The crude product was purified by automated
flash chromatography (SiO2, hexane, EtOAc 10–90%) to give 15 (0.81 g,
2.215 mmol, 53% yield) as a white solid. 1H NMR (CDCl3): d=8.90 (dd,
J=1.8, 4.2 Hz, 2H), 8.18 (dd, J=1.8, 8.3 Hz, 2H), 8.13 (dd, J=1.5,
7.2 Hz, 2H), 7.91 (s, 2H), 7.82 (dd, J=1.5, 8.2 Hz, 2H), 7.59 (m, 2H),
7.38 (dd, J=4.2, 8.3 Hz, 2H), 4.78 ppm (s, 2H); 13C NMR (CDCl3): d=
156.9, 150.1, 149.3, 145.8, 139.4, 136.5, 131.4, 128.6, 128.4, 126.5, 123.0,
120.9, 63.8 ppm; LC–MS (ESI): m/z: calcd for C24H18N3O+: 364.1
[M+H]+; found: 364.4; r.t.: 5.12 min.
Complex 4b: A suspension of 7 (46.6 mg, 0.088 mmol) and [Ru
ACHTUNGTRENNUNG(dqp)-
A
ACHTUNGTRENNUNG
4-Bromomethyl-2,6-di(quinolin-8-yl)pyridine (16):
A solution of PBr3
nBuOH (2 mL) overnight. The red solution was poured into aqueous
NH4PF6 and extracted with CH2Cl2. The organic phase was concentrated
in vacuo and the crude residue purified by flash chromatography on
silica gel (40:4:1 MeCN/H2O/KNO3 (sat.)). Fractions containing the
product were collected, concentrated in vacuo and diluted with aqueous
NH4PF6 before being extracted with CH2Cl2. The PF6 salt was suspended
in degassed MeOH/H2O (1:1) and Dowex 1 anion-exchange resin (Clꢁ
form) was added. The suspension was then stirred for 3 h, filtered and
concentrated in vacuo to give the chloride salt. This salt was then purified
by preparative HPLC (isocratic elution with H2O, 45% MeOH, 50 mm
NaHPO4, pH 7) before being isolated as the PF6 salt as described above
to give 4 (61 mg, 0.049 mmol, 55% yield) as a red solid. 1H NMR
(CD3CN): d=8.23–8.13 (m, 3H), 8.09–8.02 (m, 8H), 7.94–7.87 (m, 3H),
7.81 (dd, J=7.5, 1.3 Hz, 2H), 7.76–7.65 (m, 4H), 7.52–7.42 (m, 4H),
7.09–7.00 (m, 4H), 6.95–6.87 (m, 2H), 6.86–6.78 (m, 1H), 4.55 (d, J=
5.9 Hz, 2H), 3.80 (s, 3H), 3.71 ppm (s, 3H); 13C NMR (CD3CN): d=
164.5, 159.5, 159.4, 158.6, 157.7, 154.5, 152.5, 147.4, 143.5, 139.3, 138.7,
134.3, 134.0, 132.7, 132.5, 131.8, 131.6, 129.0, 128.0, 127.8, 127.8, 127.6,
126.1, 123.1, 123.0, 116.7, 113.2, 112.6, 56.6, 56.2, 40.0 ppm; LC–MS
(ESI): m/z: calcd for C56H41N7O3Ru2+ ([M2+]): 480.6; found: 480.8; r.t.:
4.25 min.
(0.48 mL, 5.0 mmol) in CH2Cl2 (15 mL) was added dropwise to a stirred
solution of 15 (1.5 g, 4.2 mmol) in CH2Cl2 (15 mL) under an inert atmos-
phere at 08C. The solution was allowed to warm to room temperature
and stirred overnight. The solution was recooled to 08C, quenched with
H2O (30 mL), and the aqueous layer was basified with NaHCO3 and ex-
tracted with CHCl3. The combined organic layers were dried with
Na2SO4 and concentrated in vacuo. The residue was purified by automat-
ed flash chromatography (SiO2, hexane, EtOAc 10–90%) to give 16
(1.7 g, 4.0 mmol, 94% yield) as a white solid. 1H NMR (CDCl3): d=9.00
(dd, J=1.8, 4.2 Hz, 2H), 8.29 (dd, J=1.5, 7.2 Hz, 2H), 8.24 (dd, J=1.8,
8.3 Hz, 2H), 8.18 (s, 2H), 7.89 (dd, J=1.5, 8.1 Hz, 2H), 7.67 (m, 2H),
7.46 (dd, J=4.2, 8.3 Hz, 2H), 4.67 ppm (s, 2H); 13C NMR (CDCl3): d=
157.3, 150.3, 145.9, 144.5, 138.8, 136.4, 131.6, 128.7, 128.6, 126.6, 125.6,
121.0, 32.0 ppm; LC–MS (ESI): m/z: calcd for C24H17BrN3
[M+H]+; found: 426.3; r.t.: 6.2 min.
+
: 426.1
10-{[2,6-Di(quinolin-8-yl)pyridin-4-yl]methyl}-phenothiazine (17): 10H-
PTZ (1.6 g, 7.8 mmol) in THF (10 mL) was added dropwise over 2 min to
a suspension of NaH (60%, 0.3 g, 7.8 mmol) in THF (20 mL) at 08C
under an inert atmosphere. The solution was allowed to warm to room
temperature and stirred for an additional 1 h before being recooled to
08C. Then a solution of 14 (1.7 g, 3.9 mmol) in THF (5 mL) was added
dropwise. The crude product was purified by flash chromatography
(SiO2, hexane, EtOAc 50%) to give 17 (1.6 g, 2.9 mmol, 75% yield) as
an off-white solid. 1H NMR (CDCl3): d=8.81 (dd, J=1.8, 4.1 Hz, 2H),
8.32 (dd, J=1.5, 7.2 Hz, 2H), 8.18 (dd, J=1.8, 8.3 Hz, 2H), 8.09 (s, 2H),
7.85 (dd, J=1.5, 8.1 Hz, 2H), 7.65 (dd, J=7.3, 8.1 Hz, 2H), 7.39 (dd, J=
4.2, 8.3 Hz, 2H), 7.08 (m, 4H), 6.90 (m, 4H), 5.30 ppm (s, 2H); 13C NMR
(CDCl3): d=225.3, 157.0, 150.2, 146.0, 144.7, 144.3, 139.1, 136.4, 131.6,
128.7, 128.7, 127.5, 126.7, 126.6, 124.0, 122.9, 122.6, 121.0, 116.0,
53.2 ppm; LC–MS (ESI): m/z: calcd for C36H25N4S+: 545.2 [M+H]+;
found: 545.3; r.t.: 7.89 min.
Complex 1b: Prepared as for 4b from 17 (61.8 mg, 0.102 mmol) and 19
(111 mg, 0.102 mmol), and purified by preparative HPLC (isocratic elu-
tion with H2O, 65% MeOH, 0.1% trifluoroacetic acid (TFA)) to give 1b
(77 mg, 0.051 mmol, 50% yield) as a red solid. 1H NMR (CD3CN): d=
8.18 (dd, J=5.2, 1.4 Hz, 2H), 8.09–7.98 (m, 6H), 7.87 (s, 2H), 7.79 (s,
2H), 7.74 (dd, J=7.4, 1.3 Hz, 2H), 7.69–7.63 (m, 4H), 7.47–7.34 (m, 8H),
7.26 (dd, J=7.6, 1.5 Hz, 2H), 7.20–7.14 (m, 2H), 7.09–6.99 (m, 5H),
6.96–6.84 (m, 6H), 5.36 (q, J=17.5 Hz, 2H), 3.78 (s, 3H), 3.74 (s, 3H),
2.19 ppm (s, 6H); LC–MS (ESI): m/z: calcd for C75H55N7O2RuS2+
AHCTUNGTRENNUNG
A
E
ACHTUNGTRENNUNG
[Ru(7)ACHTUNGTRENNUNG(MeCN)3]ACHTUNGTRENNUNG(PF6)2 (18): A solution of RuCl3·xH2O (248 mg,
HPLC (isocratic elution with H2O, 55% MeOH, 0.1% TFA) to give 2b
(32 mg, 0.025 mmol, 28% yield) as a red solid. 1H NMR (CD3CN): d=
8.23–8.15 (m, 3H), 8.12–8.06 (m, 6H), 7.91 (d, J=8.1 Hz, 2H), 7.79 (s,
2H), 7.78–7.72 (m, 4H), 7.71–7.66 (m, 4H), 7.38–7.50 (m, 4H), 7.37 (s,
2H), 7.06 (ddd, J=6.9, 10.6, 18.1 Hz, 5H), 6.91 (td, J=2.9, 4.2 Hz, 2H),
3.79 (s, 3H), 3.75 (s, 3H), 2.20 ppm (s, 6H); 13C NMR (CD3CN): d=
159.5, 159.4, 157.9, 157.8, 154.7, 152.2, 151.6, 147.6, 139.8, 139.1, 138.6,
138.6, 137.1, 136.0, 134.4, 134.0, 132.8, 132.6, 131.6, 129.8, 129.6, 128.9,
127.8, 127.6, 127.5, 122.9, 117.4, 114.1, 113.7, 56.6, 56.2, 20.9 ppm; LC–MS
(ESI): m/z: calcd for C62H46N6O2Ru2+ ([M2+]): 504.1; found: 503.9; r.t.:
4.73 min.
0.95 mmol) and 7 (500 mg, 0.95 mmol) was heated at reflux in EtOH
(25 mL) overnight. The resulting inorganic solid was isolated by filtration
and washed with EtOH (3ꢂ10 mL) and Et2O (3ꢂ10 mL). The solid was
dried in vacuo to give [Ru(7)Cl3] (630 mg, 0.86 mmol, 90% yield) as a
green/brown solid. The crude product (630 mg, 0.86 mmol) was suspend-
ed in a mixture of H2O (5 mL), EtOH (5 mL) and MeCN (25 mL), and
AgNO3 (481 mg, 2.8 mmol) was added. The solution was stirred at 808C
for 5 h before being filtered through celite, washed with MeCN and con-
centrated in vacuo. The crude residue was purified by flash chromatogra-
ꢁ
phy (SiO2, 40:4:1 MeCN/H2O/KNO3 (sat.)) and isolated as the PF6 salt
to give 18 as a yellow solid (830 mg, 0.80 mmol, 84% yield over two
steps). 1H NMR (CD3CN): d=9.07 (dd, J=5.1, 1.4 Hz, 2H), 8.63–8.60
(m, 4H), 8.28 (dd, J=8.2, 1.2 Hz, 2H), 8.24 (s, 2H), 7.93 (dd, J=8.1,
7.6 Hz, 2H), 7.85 (t, J=5.8 Hz, 1H), 7.67 (dd, J=8.2, 5.2 Hz, 2H), 6.92–
6.79 (m, 3H), 4.55 (d, J=5.8 Hz, 2H), 3.79 (s, 3H), 3.70 (s, 3H), 2.44 (s,
6H), 2.15 ppm (s, 3H); 13C NMR (CD3CN): d=164.5, 159.8, 159.2, 154.6,
152.7, 147.2, 144.4, 139.8, 135.2, 135.2, 133.3, 129.7, 129.2, 128.1, 127.6,
126.2, 123.36, 116.7, 113.4, 112.7, 56.7, 56.3, 40.2, 4.6, 3.9 ppm; LC–MS
Complex 3b: Prepared as for 4b from 17 (209 mg, 0.384 mmol) and 18
(400 mg, 0.384 mmol), and purified by preparative HPLC (65% MeOH
in H2O) to give 3b (335 mg, 0.229 mmol, 60% yield) as a red solid.
1H NMR (CD3CN): d=8.15 (s, 2H), 8.07–7.99 (m, 6H), 7.94 (dd, J=5.2,
1.4 Hz, 2H), 7.85 (s, 2H), 7.84–7.76 (m, 3H), 7.69–7.62 (m, 4H), 7.49–
7.36 (m, 6H), 7.25 (dd, J=7.6, 1.5 Hz, 2H), 7.19–7.10 (m, 2H), 7.06–6.98
(m, 4H), 6.94–6.79 (m, 7H), 5.35 (q, J=17.4 Hz, 2H), 4.55 (d, J=5.9 Hz,
2840
ꢁ 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2010, 16, 2830 – 2842